Please click here to obtain permission to reproduce this image.
Click on image to view larger version.
Figure 1 Patient Flow
*One patient was randomized to aliskiren 300 mg but did not have any baseline or post-baseline evaluations and was not included in numbers completing or discontinuing.
|
